Editorial Guidelines

Our Mission

Myostatin Inhibitors Hub exists to give people honest, specific, plain-language answers about myostatin inhibitors — the biology, the drugs, and the protocols built around them. Most of what's online about this category is either marketing copy or hedged-to-uselessness clinical summary. We aim to be the in-between: clinically accurate, but written for the person actually deciding what to do.

Who We Write For

Our readers are adults researching myostatin inhibition for themselves — usually for muscle preservation, sarcopenia, recovery from injury, or performance. We write in human-use framing because that's the question being asked. Nothing on this site is medical advice, and we say so at the bottom of every relevant article.

Research Standards

Every article must, before publishing:

• Survey the current evidence landscape — clinical trials, regulatory filings, and reputable medical references — so we cover the drugs, mechanisms, and questions a careful reader would expect to see.
• Cite primary literature where dose ranges, mechanism claims, percentages, or trial outcomes are stated. Peer-reviewed sources outrank secondary summaries.
• Distinguish what is established (human trial evidence) from what is preliminary (early-stage or limited data) using plain language, not hedging adverbs.
• Use specific numbers — dose, weeks, percentages, costs — instead of vague claims like “supports” or “may help.”

Sourcing

We prefer, in order: peer-reviewed journals, regulatory filings and clinical trial registries, major academic medical centers (Mayo, Cleveland Clinic, NIH/NIDDK), reputable medical reference sites, and primary manufacturer documentation. Forum posts and anecdotal reports are useful for framing reader questions but are never the basis of a clinical claim.

Medical & Expert Review

Articles that include dosing, side effects, drug interactions, or contraindications are reviewed by a clinician before publishing. When this review has been completed, the reviewer's initials and the review date appear at the top of the article. Articles without a reviewer credit have not yet completed clinical review.

Use of AI

We use AI tools to assist with research, outlining, and editing. Every article is fact-checked against primary sources by a human editor before publishing. We do not publish AI-generated content that hasn't been verified, rewritten, and reviewed.

Conflicts of Interest & Affiliate Disclosure

Some articles include affiliate links to vendors and products. We disclose this on the article itself. Affiliate relationships never decide what we recommend — we've explicitly excluded vendors from recommendations when their product or service didn't meet our standards, and we name the limitation either way.

Updates & Freshness

Every article carries a “Last Updated” badge under the headline. We refresh articles whenever new clinical data, dose guidance, or pricing changes the answer — not on a fixed cadence. The badge reflects the date of the most recent meaningful edit, not cosmetic changes.

Corrections Policy

If we discover an error in published content, we correct it promptly and transparently. Significant corrections — anything that changes a clinical recommendation, dose, or factual claim — are noted at the top of the affected article with the date of the correction. To report an error, see the contact information on our About page.

What We Will Not Publish

• Recommendations that contradict primary clinical evidence to favor an affiliate partner.
• Articles that haven't been cross-checked against the underlying clinical literature.
• Dose, route, or stack guidance that hasn't been cross-checked against published protocols.
• Content framed as medical advice or as a substitute for talking to a clinician.